骨骼肌MRI在杜氏肌营养不良症诊断及疾病进展监测中的应用
Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy.
作者信息
Finanger Erika L, Russman Barry, Forbes Sean C, Rooney William D, Walter Glenn A, Vandenborne Krista
机构信息
Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239, USA.
出版信息
Phys Med Rehabil Clin N Am. 2012 Feb;23(1):1-10, ix. doi: 10.1016/j.pmr.2011.11.004. Epub 2011 Dec 14.
Abstract
Studies have shown promise in using various approaches of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy to evaluate skeletal muscle involvement in Duchenne muscular dystrophy. However, these studies have mainly been performed using a cross-sectional design, and the correlation of these MRI changes with disease progression and disease severity has not been fully elucidated. Overall, skeletal muscle MRI is a powerful and sensitive technique in the evaluation of muscle disease, and its use as a biomarker for disease progression or therapeutic response in clinical trials deserves further study.
摘要
研究表明，使用各种磁共振成像（MRI）和磁共振波谱方法来评估杜氏肌营养不良症中的骨骼肌受累情况具有前景。然而，这些研究主要采用横断面设计，且这些MRI变化与疾病进展和疾病严重程度之间的相关性尚未完全阐明。总体而言，骨骼肌MRI在评估肌肉疾病方面是一种强大且敏感的技术，其在临床试验中作为疾病进展或治疗反应的生物标志物的应用值得进一步研究。
相似文献
1
Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy.
Phys Med Rehabil Clin N Am. 2012 Feb;23(1):1-10, ix. doi: 10.1016/j.pmr.2011.11.004. Epub 2011 Dec 14.
2
Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.
Biomark Med. 2021 Jun;15(10):761-773. doi: 10.2217/bmm-2020-0801. Epub 2021 Jun 22.
3
Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.
AJR Am J Roentgenol. 2008 Jan;190(1):W8-12. doi: 10.2214/AJR.07.2732.
4
Localized MRI and histological image correlation in a canine model of duchenne muscular dystrophy.
Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:4083-4086. doi: 10.1109/EMBC.2016.7591624.
5
A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
Int J Comput Assist Radiol Surg. 2013 Sep;8(5):763-74. doi: 10.1007/s11548-012-0810-6. Epub 2013 Jan 9.
6
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.
Neurotherapeutics. 2020 Jan;17(1):142-152. doi: 10.1007/s13311-019-00825-1.
7
Modeling disease trajectory in Duchenne muscular dystrophy.
Neurology. 2020 Apr 14;94(15):e1622-e1633. doi: 10.1212/WNL.0000000000009244. Epub 2020 Mar 17.
8
Na MRI depicts early changes in ion homeostasis in skeletal muscle tissue of patients with duchenne muscular dystrophy.
J Magn Reson Imaging. 2019 Oct;50(4):1103-1113. doi: 10.1002/jmri.26681. Epub 2019 Feb 4.
9
MRI Evaluation of Gene Therapy in the Canine Model of Duchenne Muscular Dystrophy.
Methods Mol Biol. 2023;2587:339-352. doi: 10.1007/978-1-0716-2772-3_17.
10
Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.
Ann Neurol. 2016 Apr;79(4):535-47. doi: 10.1002/ana.24599. Epub 2016 Feb 19.
引用本文的文献
1
Importance of neural network complexity for the automatic segmentation of individual thigh muscles in MRI images from patients with neuromuscular diseases.
MAGMA. 2025 Apr;38(2):175-189. doi: 10.1007/s10334-024-01221-3. Epub 2025 Jan 11.
2
Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular Dystrophy.
Muscle Nerve. 2025 Mar;71(3):353-359. doi: 10.1002/mus.28323. Epub 2024 Dec 24.
3
Severity of muscle impairment and its progression assessed using musculoskeletal magnetic resonance imaging and diffusion tension imaging in 78 boys with Duchenne muscular dystrophy: a retrospective study.
Pol J Radiol. 2024 Feb 19;89:e88-e105. doi: 10.5114/pjr.2024.135718. eCollection 2024.
4
Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
Skelet Muscle. 2023 Nov 18;13(1):19. doi: 10.1186/s13395-023-00331-1.
5
Clinical applications of skeletal muscle diffusion tensor imaging.
Skeletal Radiol. 2023 Sep;52(9):1639-1649. doi: 10.1007/s00256-023-04350-3. Epub 2023 Apr 21.
6
Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders.
Sci Rep. 2023 Feb 13;13(1):2538. doi: 10.1038/s41598-023-29759-7.
7
Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature.
Medicina (Kaunas). 2022 Mar 17;58(3):440. doi: 10.3390/medicina58030440.
8
Generation of a Dystrophin Mutant in Dog by Nuclear Transfer Using CRISPR/Cas9-Mediated Somatic Cells: A Preliminary Study.
Int J Mol Sci. 2022 Mar 7;23(5):2898. doi: 10.3390/ijms23052898.
9
Typical m. triceps surae morphology and architecture measurement from 0 to 18 years: A narrative review.
J Anat. 2022 Apr;240(4):746-760. doi: 10.1111/joa.13584. Epub 2021 Nov 8.
10
Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy.
Neuromuscul Disord. 2021 Aug;31(8):736-751. doi: 10.1016/j.nmd.2021.05.010. Epub 2021 Jun 2.
本文引用的文献
1
Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy.
Neuromuscul Disord. 2012 Jan;22(1):16-25. doi: 10.1016/j.nmd.2011.06.750. Epub 2011 Jul 31.
2
Muscle histology vs MRI in Duchenne muscular dystrophy.
Neurology. 2011 Jan 25;76(4):346-53. doi: 10.1212/WNL.0b013e318208811f.
3
In vivo 31P MRS detection of an alkaline inorganic phosphate pool with short T1 in human resting skeletal muscle.
NMR Biomed. 2010 Oct;23(8):995-1000. doi: 10.1002/nbm.1517.
4
Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.
Arch Phys Med Rehabil. 2010 Jul;91(7):1051-8. doi: 10.1016/j.apmr.2010.03.024.
5
T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.
Radiology. 2010 Jun;255(3):899-908. doi: 10.1148/radiol.10091547.
6
MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise.
J Magn Reson Imaging. 2009 Nov;30(5):1130-8. doi: 10.1002/jmri.21941.
7
Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
J Comput Assist Tomogr. 2009 Jan-Feb;33(1):150-4. doi: 10.1097/RCT.0b013e318168f735.
8
Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
Eur J Paediatr Neurol. 2009 Jan;13(1):34-40. doi: 10.1016/j.ejpn.2008.02.006. Epub 2008 Apr 11.
9
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.
Ann Neurol. 2008 May;63(5):561-71. doi: 10.1002/ana.21338.
10
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003725. doi: 10.1002/14651858.CD003725.pub3.
Zotero 插件